Abbott Laboratories Inc. (ABT) is in the Pharma Industry

• Sort by
• View Related Content by Tag

• Takeda Sees Big Profit Slump on Millennium Costs

  By Edwina Gibbs TOKYO (Reuters) - Japan's Takeda Pharmaceutical Co Ltd posted a 77 percent drop in quarterly operating profit as it spent to boost its pipeline, and forecast a sharp fall in annual income linked to the costs of its $8...

  News items 2008-05-09

  Tags: Millennium Pharmaceuticals Inc., VELCADE, Amgen Inc., biotechnology, pharmaceutical company, Tokyo, Merrill Lynch & Co. Inc., earnings, analyst, stock, Thomson Reuters Corp., acquisition, U.S., sales, agreement, benefit

• Cholesterol-drug Rejection Rips New Gash in Merck

  By Ransdell Pierson NEW YORK (Reuters) - Confidence in Merck & Co's MRK earnings prospects withered on Tuesday, along with its stock price, after U.S. regulators surprisingly rejected the drugmaker's treatment to raise levels of "good" HDL cholesterol. Shares of Merck,...

  News items 2008-04-29

  Tags: Financial accounting, Merck & Co. Inc., vaccine, earnings, analyst, cost control, DJIA, Thomson Reuters Corp., New York, U.S., sales, CEO, manufacturing, strategy

• Wyeth Profit Hurt By Generics

  NEW YORK (Reuters) - Wyeth WYE posted slightly lower first-quarter earnings on Tuesday, hurt by the recent launch of generic forms of its Protonix ulcer drug, but surprisingly strong sales of other medicines enabled the company to beat Wall Street profit...

  News items 2008-04-22

  Tags: Sales strategy, Sales force management, Wyeth, pharmaceutical company, sales, earnings, New York, Thomson Reuters Corp., revenue, Sun Microsystems Inc., U.S., asset

• Abbott Profit Up on Drugs Sales

  By Ransdell Pierson NEW YORK (Reuters) - Abbott Laboratories Inc ABT said on Wednesday first-quarter earnings increased 34 percent on higher sales of its prescription drugs and medical devices and favorable foreign exchange factors. The company reported strong sales gains for its top...

  News items 2008-04-16

  Tags: Sales strategy, Sales force management, HEALTHCARE, Abbott Laboratories Inc., prescription drug, Johnson & Johnson, foreign-exchange, medical device, diagnostics, earnings, sales, New York, Thomson Reuters Corp., net profit, U.S., analyst, stock, industry, benefit

Additional Resources

• Mylan Announces Final FDA Approval for Trandolapril Tablets

  PITTSBURGH, April 29 /PRNewswire-FirstCall/ -- Mylan Inc. today announced that Mylan Pharmaceuticals Inc. has received final approval from the U.S. Food and Drug Administration FDA for its Abbreviated New Drug Application ANDA for Trandolapril Tablets, 1 mg, 2 mg and 4 mg. Trandolapril Tablets are the...

  Articles 2008-04-29

• Seven Summits Research Releases Comments on MS, HAL, AMR, UA, and ABT

  CHICAGO, April 29 /PRNewswire/ -- Seven Summits Research releases NewsBites on key stocks. Seven Summits Strategic Investments NewsBites are available to all investors at: http://www.go7now.com/nb/0429Y (Note: You may have to copy this link into your browser then press the [ENTER] key.) Today's Seven...

  Articles 2008-04-29

• Zacks Releases Four "Strong Buy" or "Buy" Stocks: Big Lots, Abbott Laboratories, Cellcom Israel Ltd. and Mirant Corporation

  CHICAGO -- Four free stock picks are being made available today on Zacks.com. The industry's leading independent research firm highlights a Zacks #1 Rank Strong Buy stock or a Zacks #2 Rank Buy stock for each of the four main styles of investing: Aggressive Growth, Growth & Income, Momentum, and...

  Articles 2008-04-24

• ImaRx Therapeutics Satisfies Abbott Note Obligation Associated With the Acquisition of Urokinase

  TUCSON, Ariz., April 23 /PRNewswire-FirstCall/ -- ImaRx Therapeutics, Inc. today announced that it has entered into an agreement with Abbott Laboratories pursuant to which it has satisfied its obligations under its $15 million non-recourse promissory note with Abbott issued in connection with its acquisition of urokinase. As...

  Articles 2008-04-23

• SectorWatch.biz Issues MarketStats on KBLB, DGX, LH, BRLI, and ABT

  IRVINE, Calif., April 23 /PRNewswire/ -- SectorWatch.biz announces the availability of MarketStats on public equities in the news and driving markets today within the biotechnology and diagnostic testing arena. MarketStats offers a perspective on the aforementioned equities and the opportunity for investors to respond with articles and opinions on...

  Articles 2008-04-23

• WebLOQ Appoints David Milligan and Robert Ditmore to Board of Directors

  Former Abbott Labs Chief Scientific Officer and Former President and Chief Operating Officer of United HealthCare Corporation Join Board of Emerging Security Technology Company SANTA CLARA, Calif., April 22 /PRNewswire/ -- WebLOQ, Inc., the emerging leader in total privacy solutions for secure and compliant eBusiness and data-in-motion...

  Articles 2008-04-22

• MDS Appoints Two New Directors

  Gregory Spivy and William Dempsey join MDS Board TORONTO, April 21 /PRNewswire-FirstCall/ -- MDS Inc. (TSX: MDS; NYSE: MDZ), a leading provider of products and services to the global life sciences markets, today announced that Mr. Gregory Spivy, Partner at ValueAct Capital, and Mr. William Dempsey, former...

  Articles 2008-04-21

• Seven Summits Research Releases Comments on IBM, ABT, CAT, DD and TXT

  CHICAGO, April 14 /PRNewswire/ -- Seven Summits Strategic Investments releases its Stocks To Watch Guide. The Seven Summits Strategic Investments Stocks To Watch Guide (go to: http://www.iotogo.com/StocksToWatch) provides investors with essential information on stocks that may be poised for a significant move. By featuring hedged...

  Articles 2008-04-14

• Miraculins Appoints Director of Research and Development

  Miraculins Inc. (TSX VENTURE: MOM), a biotechnology company dedicated to the discovery and development of diagnostic tools and therapeutic products for cancer, is pleased to announce that Stephan J. Frost, PhD, has been appointed Director, Research and Development. "I am very pleased that Dr. Frost has accepted the offer to...

  Articles 2008-04-14

• Zacks Analyst Blog Highlights: Washington Mutual, LifeCell Corporation, Kinetic Concepts, Johnson & Johnson and Abbott Laboratories

  CHICAGO -- Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include: Washington Mutual (NYSE: WM), LifeCell Corporation (Nasdaq: LIFC), Kinetic Concepts, Inc....

  Articles 2008-04-08

• Light Sciences Oncology Appoints David P. Holveck to Its Board of Directors

  BELLEVUE, Wash., April 7, 2008 /PRNewswire/ -- Light Sciences Oncology, Inc. LSO today announced the appointment of David P. Holveck to its Board of Directors. The appointment increases Board membership to eight. Holveck, 62, is the President, Chief Executive Officer and a Director of Endo Pharmaceuticals. He...

  Articles 2008-04-07

• Abbott Laboratories Review in Progress.

  M2 PRESSWIRE-4 April 2008-The Maybach Review: Abbott Laboratories Review in ProgressC1994-2008 M2 COMMUNICATIONS LTD RDATE:04042008 MaybachFinancial.com is one of the fastest growing independent and unbiased research firms in the world. Investors wanting to know the truth about investing and...

  Articles 2008-04-04

• Adaltis Appoints Chief Operating Officer for China

  Adaltis Inc. (TSX: ADS), an international in vitro diagnostic IVD company, today announced the appointment of Mr. Frederick Leung to the newly created position of Chief Operating Officer - China, reporting to Dr. Raymond Tong, Chief Operating Officer of the Company. Mr. Frederick Leung has an extensive background in the...

  Articles 2008-04-03

• Adaltis Appoints Chief Operating Officer for China.

  MONTREAL, QUEBEC, Apr 3, 2008 Marketwire via COMTEX -- Adaltis Inc. (TSX:ADS), an international in vitro diagnostic IVD company, today announced the appointment of Mr. Frederick Leung to the newly created position of Chief Operating Officer - China, reporting to Dr. Raymond Tong, Chief Operating Officer...

  Articles 2008-04-03

• Bioscience Career Fair in San Francisco Projected to Break Job Seeker Attendance Records

  SAN FRANCISCO, April 2, 2008 /PRNewswire/ -- BioSpace, the world's leading online bioscience job board and life science career fair company, will host the Biotech BayTM Career Fair on Tuesday, May 6, 2008. The event will take place at the San Francisco Airport Marriott from 2 pm to 7...

  Articles 2008-04-02

• Abbott Laboratories Review in Progress.

  M2 PRESSWIRE-1 April 2008-MG Strategies: Abbott Laboratories Review in ProgressC1994-2008 M2 COMMUNICATIONS LTD RDATE:01042008 MaybachFinancial.com is one of the fastest growing independent and unbiased research firms in the world. Investors wanting to know the truth about investing and how...

  Articles 2008-04-01